Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID‐19 Outbreak
Open Access
- 25 October 2020
- journal article
- research article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 8 (1) , 60-68
Abstract
Background: Following the severe consequences of the COVID‐19 outbreak, on March 9, 2020, the Italian government implemented extraordinary measures to limit viral transmission, including restrictive quarantine measures. This resulted in a rapid and profound change of people's daily lives.Objective: We assessed the psychological impact of the 40‐day quarantine in a large cohort of patients with Parkinson's disease (PD) and caregivers. Moreover, we analyzed whether prelockdown clinical features may be associated with subjective response of patients with PD to this traumatic event.Methods: A total of 94 patients with PD were enrolled in the study. The Impact of Event Scale‐Revised, the Kessler Psychological Distress Scale, and the 12‐item Zarit Burden Inventory were obtained from patients and caregivers by email. A multivariate regression analysis was performed to determine whether prelockdown clinical motor and nonmotor features were associated with the psychological impact of lockdown.Results: Regression analyses showed that prelockdown levels of anxiety, treatment‐related motor complications, patients' quality of life, and lockdown hours per day were significantly associated with psychological impact measures of the 40‐day quarantine. In addition, we showed that caregiver burden was correlated with overall patient autonomy and attention/memory impairment.Conclusions: We identified specific PD motor and nonmotor features potentially predisposing to higher psychological impact of stressful situations, such as quarantine. This may help guide postpandemic interventions and preventive strategies to avoid further impairment of psychological well‐being in patients with PD.Keywords
This publication has 44 references indexed in Scilit:
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicineJournal of Neurology, Neurosurgery & Psychiatry, 2007
- The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot studyMovement Disorders, 2007
- Understanding, compliance and psychological impact of the SARS quarantine experienceEpidemiology and Infection, 2007
- Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptorThe EMBO Journal, 2007
- The experience of SARS-related stigma at Amoy GardensSocial Science & Medicine, 2005
- Factors Influencing Compliance with Quarantine in Toronto During the 2003 SARS OutbreakBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2004
- The Zarit Burden InterviewThe Gerontologist, 2001
- Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnoverAnnals of Neurology, 2001
- ParkinsonismNeurology, 1967